US Archives - Page 33 of 119 - European Medical Journal

Can Eye Drops Heal Scars? Timolol Tested After Mammoplasty

A randomized controlled trial reveals that topical timolol may offer an effective and non-invasive solution to improve the appearance of immature scars following mammoplasty surgery.

Mispriced Adverse Events Distort Cancer Drug Cost-Effectiveness

In the high-stakes landscape of cancer treatment where healthcare professionals rely on cost-effectiveness analyses to guide decisions adverse event costs may be throwing off the equation.

US Sees Growing Mortality Burden from Vascular Dementia

A new study examining vascular dementia (VaD) mortality in the United States from 2005 to 2020 reveals a marked rise in age-adjusted death rates, especially in specific regions and demographic groups.

FDA Approves Powdered Treprostinil Inhalation for Pulmonary Hypertension

THE U.S. Food and Drug Administration has approved a novel inhaled formulation of treprostinil for adults with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), adding a new option for improving exercise ability in these patient populations.

Lipid-Rich Emulsion Outperforms Standard Cream in Eczema Study

A new dermatology study offers compelling evidence that targeted lipid supplementation can restore the skin barrier in adults with a history of atopic dermatitis, outperforming commonly used emollients.

Pediatric Acute Respiratory Infections Risks in Mexico Investigated

A cross-sectional study conducted at the Hospital Infantil de México “Federico Gómez” has shed new light on the demographic and clinical factors driving pediatric respiratory infections in Latin America.

Early Heart Risks After Stem Cell Transplant Revealed

A new study sheds light on the hidden cardiovascular risks lurking in the critical first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT).

Can AI Predict Stroke Complications Before They Strike?

In a breakthrough meta-analysis designed for clinicians and healthcare professionals, machine learning tools have shown promising accuracy in predicting hemorrhagic transformation (HT) in patients with acute ischemic stroke (AIS).

Phase III Trial Results: Nerandomilast in Pulmonary Fibrosis

In a Phase III clinical trial, nerandomilast, an oral phosphodiesterase 4B inhibitor, was associated with a smaller decline in lung function over 52 weeks in patients with progressive pulmonary fibrosis, when compared with placebo.

Invasive Candidiasis Management Gaps in ICUs Shared in 2024 Survey

Invasive candidiasis remains a significant challenge for intensive care units worldwide due to its high mortality rate, diagnostic complexity, and increasing resistance.